Oncotelic Therapeutics, Inc.
General ticker "OTLC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $21.3M (TTM average)
Oncotelic Therapeutics, Inc. follows the US Stock Market performance with the rate: 25.4%.
Estimated limits based on current volatility of 4.6%: low 0.09$, high 0.10$
Factors to consider:
- Total employees count: 22 (0.0%) as of 2023
- Top business risk factors: Product development risks, Economic downturns and volatility, Manufacturing risks, Intellectual property risks, Climate change and natural disasters
- Current price 72.8% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.02$, 0.05$]
- 2024-12-30 to 2025-12-30 estimated range: [0.02$, 0.05$]
Financial Metrics affecting the OTLC estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.65 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 40.41 <= 41.86
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: Industry earnings per price (median), % of -22.08 <= 0
Short-term OTLC quotes
Long-term OTLC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.07MM |
| Operating Expenses | $9.13MM | $9.72MM | $6.72MM |
| Operating Income | $-9.13MM | $-9.72MM | $-6.65MM |
| Non-Operating Income | $-1.39MM | $14.40MM | $-1.56MM |
| Interest Expense | $2.00MM | $2.97MM | $1.04MM |
| R&D Expense | $3.66MM | $0.76MM | $0.06MM |
| Income(Loss) | $-10.52MM | $4.68MM | $-8.21MM |
| Profit(Loss)* | $-11.39MM | $5.09MM | $-7.90MM |
| Stockholders Equity | $7.96MM | $19.41MM | $12.13MM |
| Inventory | $0.02MM | $0.00MM | $0.00MM |
| Assets | $23.61MM | $36.12MM | $30.01MM |
| Operating Cash Flow | $-4.43MM | $-1.45MM | $-1.32MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $4.53MM | $1.13MM | $1.25MM |
| Earnings Per Share** | $-0.04 | $0.01 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.